Core FFO outperformance and raised guidance: Q3 2025 Core FFO exceeded guidance by $0.01/share, prompting management to raise full-year 2025 guidance to $6.85/share midpoint (from $6.81), reflecting strong execution and favorable financing environment Same property NOI growth stalled materially: Growth decelerated sharply to 0.0% YoY in Q3 2025, a concerning inflection point as expense growth of…

Our analysis rates this filing NEUTRAL. The elevated concern level (5.5/10) reflects a balanced but cautiously negative picture. While Camden beat quarterly earnings expectations and raised full-year guidance—both positive signals—the underlying operational metrics reveal concerning trends. The…

Concern level: ELEVATED (5.5/10). Key factors: Same property NOI growth stagnated at 0.0% year-over-year in Q3 2025, representing significant deceleration from positive growth in prior periods; Expense growth of 2.3% significantly outpacing revenue growth of 0.8%, indicating margin compression at the property level; Sequential NOI decline of -0.6% from Q2 to Q3 2025 suggests deteriorating…

Notable risk changes: Third quarter 2025 Core FFO outperformed guidance by $0.01 per share, indicating positive operational execution; Full-year 2025 Core FFO guidance raised from $6.81 to $6.85 per share midpoint due to outperformance and favorable financing conditions; Same property NOI growth decelerated to 0.0% year-over-year in Q3 2025 (vs. prior quarters), driven by expense growth of 2.3% outpacing revenue…

The model predicts CPT will outperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.